Institutional investors purchased a net $1.3 million shares of NUVA during the quarter ended December 2017 and now own 108.16% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Medical Specialties industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
AXA INVESTMENT MANAGERS UK LTD. Bought 787.3 Thousand shares of NuVasive Inc
CITADEL ADVISORS LLC Bought 741.4 Thousand shares of NuVasive Inc
CARILLON TOWER ADVISERS, INC. Bought 739.0 Thousand shares of NuVasive Inc